Evidence map›Paper›PMID 16437161›Full record

ArticleThe EMBO journal2006

Global and gene-specific analyses show distinct roles for Myod and Myog at a common set of promoters.

Yi Cao, Roshan M Kumar, Bennett H Penn, Charlotte A Berkes, Charles Kooperberg, Laurie A Boyer, Richard A Young, Stephen J Tapscott

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 152 papers.

0numbers the graph read from it
0cells of the map it votes in
152citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

152 citing papers in PubMed, 289 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Tissue-Specific Expression of the PorcineAnimals : an open access journal from MDPI · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. A dysfunctional miR-1-TRPS1-MYOG axis drives ERMS by suppressing terminal myogenic differentiation.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
  18. Article
  19. Article
  20. Article

92 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yi CaoFred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
Roshan M Kumar
Bennett H Penn
Charlotte A Berkes
Charles Kooperberg
Laurie A Boyer
Richard A Young
Stephen J Tapscott
Fred Hutch Cancer Center · USWhitehead Institute for Biomedical Research · US

Funding

Transcriptional Regulatory Networks in Living CellsR01HG002668 · NHGRI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI YOUNG, RICHARD · 2003 to 2016
$17.9M
LINEAGE DETERMINATION IN MUSCLER01AR045113 · NIAMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TAPSCOTT, STEPHEN J · 1998 to 2017
$6.8M
Human Cell Cycle Transcriptional Regulatory NetworksR01GM069400 · NIGMS · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI YOUNG, RICHARD A · 2004 to 2006
$1.8M
Adaptive Function Estimation for Genomic DataR01CA074841 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KOOPERBERG, CHARLES L · 2003 to 2006
$1.1M
HAZARD REGRESSION AND OTHER POLYNOMIAL SPLINE METHODSR29CA074841 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KOOPERBERG, CHARLES L · 1998 to 2002
$351k
Causal Role for DNMT1 in C-T Mutations and TumorigenesisF32CA094664 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI BOYER, LAURIE A · 2002 to 2004
$134k
NCI NIH HHS CA094664NCI NIH HHS CA74841NCI NIH HHS F32 CA094664NCI NIH HHS R01 CA074841NCI NIH HHS R29 CA074841NHGRI NIH HHS HG002668NHGRI NIH HHS R01 HG002668NIAMS NIH HHS AR45113NIAMS NIH HHS R01 AR045113NIGMS NIH HHS GM069400NIGMS NIH HHS R01 GM069400
6 · The paper itself

Abstract

We used a combination of genome-wide and promoter-specific DNA binding and expression analyses to assess the functional roles of Myod and Myog in regulating the program of skeletal muscle gene expression. Our findings indicate that Myod and Myog have distinct regulatory roles at a similar set of target genes. At genes expressed throughout the program of myogenic differentiation, Myod can bind and recruit histone acetyltransferases. At early targets, Myod is sufficient for near full expression, whereas, at late expressed genes, Myod initiates regional histone modification but is not sufficient for gene expression. At these late genes, Myog does not bind efficiently without Myod; however, transcriptional activation requires the combined activity of Myod and Myog. Therefore, the role of Myog in mediating terminal differentiation is, in part, to enhance expression of a subset of genes previously initiated by Myod.

Indexed as

Gene Expression ProfilingPromoter Regions, GeneticAcetylationAnimalsCell DifferentiationCells, CulturedGene Expression RegulationGenomeHistone AcetyltransferasesHistonesMiceMuscle, SkeletalMyoD ProteinMyogeninOligonucleotide Array Sequence AnalysisProtein BindingHistone AcetyltransferasesHistonesMyoD ProteinMyogeninMyog protein, mouse

Identifiers

PMID16437161
PMCPMC1383539
OpenAlexW2139581284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.